SCHEMBL27612525

SCHEMBL27612525

N#Cc1cccc(-c2nc(N)nc(N)c2F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 11/20 0.63
▸ ADORA1 P30542 10/20 0.63
▸ ADORA2B P29275 6/20 0.51
▸ PIK3CD O00329 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ EGFR P00533 1/20 0.44
▸ HCK P08631 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ KDR P35968 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ PIK3CG P48736 1/20 0.44
▸ EPHB4 P54760 1/20 0.44
▸ PRKDC P78527 1/20 0.44
▸ PI4KB Q9UBF8 1/20 0.44
▸ DHFR P00374 1/20 0.44
▸ CHUK O15111 1/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ XDH P47989 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27612727 0.86 ADORA2A (0.54) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL28753644 0.81 ADORA1 (0.49) ADORA2AADORA1ADORA2BCHUK
SCHEMBL28753638 0.80 ADORA1 (0.59) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL27631687 0.80 ADORA2A (0.45) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL26795972 0.79 ADORA2A (0.59) ADORA2AADORA1ADORA2BDHFRCLK4
Hydrochloric Acid SCHEMBL27631852 0.78 ADORA2A (0.44) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL4419371 0.77 HRH2 (0.47) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL19932545 0.77 ADORA2A (0.43) ADORA2AADORA1ADORA2BPIK3CDABL1
SCHEMBL4411196 0.77 RAB9A (0.56) ADORA2AADORA1ADORA2BSRCPIK3CG
SCHEMBL1116418 0.77 PIK3CG (0.60) ADORA2AADORA1ADORA2BPIK3CDABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
Send feedback